期刊文献+

白芍总苷对TNBS诱导的大鼠实验性结肠炎的影响 被引量:18

Effect of Total Glucosides of Paeony on TNBS-induced Experimental Colitis in Rats
下载PDF
导出
摘要 背景:白芍总苷(TGP)具有抗炎、免疫调节等作用,其对炎症性肠病是否具有治疗作用尚不清楚。目的:探讨TGP对大鼠实验性结肠炎的影响及其可能机制。方法:50只大鼠以三硝基苯磺酸(TNBS)/乙醇溶液灌肠诱导结肠炎模型,分为结肠炎模型组、低、中、高剂量TGP组(25、50、100mg/kgTGP)和阳性药物对照组(100mg/kg奥沙拉秦)。10只大鼠作为正常对照组(0.9%NaCl溶液灌肠)。实验期间评估各组疾病活动指数(DAI);干预2周后行结肠大体损伤指数(CMDI)和组织学损伤指数(TDI)评分,以酶联免疫吸附测定(ELISA)检测血清肿瘤坏死因子-α(TNF-α)和白细胞介素-10(IL-1O)水平,以免疫组化方法检测结肠组织磷酸化p38丝裂原活化蛋白激酶(p—p38MAPK)表达。结果:与结肠炎模型组相比,高剂量TGP组实验期间DAI均值显著降低(P<0.01);中、高剂量TGP组CMDI和TDI显著降低,血清TNF-α水平降低,IL-10水平升高,结肠组织p-p38MAPK表达降低(P<0.05)。高剂量TGP的疗效与奥沙拉秦无明显差异。结论:TGP可能通过抑制p38MAPK激活,抑制TNF-α分泌,促进IL—10分泌,改善免疫调节紊乱,从而减轻TNBS诱导的大鼠实验性结肠炎的症状和结肠炎性损伤。 Background:The total glucosides of paeony (TGP) have the function of anti-inflammation and immunoregulation, but its therapeutic effect on inflammatory bowel disease is still uncertain. Aims: To investigate the effect of TGP on experimental colitis in rats and its potential mechanism. Methods: Colitis model was induced in 50 rats by rectal administration of trinitrobenzene sulfonie acid (TNBS) dissolved in ethanol. Ten model rats each were treated with 25, 50 and 100 mg/kg TGP, respectively, 10 model rats served as model control group, and 10 model rats were treated with 100 mg/kg olsalazine as drug controls. Other 10 rats receiving 0.9% NaCl solution served as normal controls. Disease activity index (DAI) was evaluated during the intervention. After 2-week intervention, the colonic macroscopic damage index (CMDI) and tissue damage index (TDI) were evaluated, the serum levels of tumor necrosis factor-or (TNF-α) and interleukin-10 (IL-10) were determined by enzyme-linked immunosorbent assay (ELISA), and the colonic expression of phosphorylated p38 mitogen-activated protein kinase (p-p38MAPK) was determined by immunohistochemical method.Results: Compared with model control group, DAI in high-dose TGP group during the intervention decreased significantly (P〈0.01); CMDI and TDI, as well as the serum level of TNF-α and the colonic expression of p-p38MAPK in moderate- and high-dose TGP groups decreased significantly, while the serum level of IL-10 increased significantly (P〈0.05). No statistically significant differences were found between high-dose TGP group and olsalazine group. Conclusions: TGP can attenuate the symptoms and colonic inflammatory damage of TNBS-induced experimental colitis in rats. The mechanism may be related to the inhibition of p38MAPK activation, down-regulation of TNF-α, up-regulation of IL-10 and improvement of immunoregulation.
出处 《胃肠病学》 2009年第3期154-158,共5页 Chinese Journal of Gastroenterology
关键词 结肠炎 溃疡性 白芍总苷 P38丝裂原活化蛋白激酶类 肿瘤坏死因子α 白细胞介素10 Colitis, Ulcerative, Total Glucosides of Paeony p38 Mitogen-Activated Protein Kinases Tumor Necrosis Factor-alpha Interleukin-10
  • 相关文献

参考文献9

  • 1Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med, 2000, 51: 289-298.
  • 2戴亦晖,王小虹,戴晓东.白芍总甙的药理作用及其应用[J].中华临床医学卫生杂志,2006,4(5):27-28. 被引量:13
  • 3Morris GP, Beck PL, Herridge MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology, 1989, 96 (3): 795-803.
  • 4Murano M, Maemura K, Hirata I, et al. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol, 2000, 120 (1): 51-58.
  • 5王皓,欧阳钦,胡仁伟.三硝基苯磺酸结肠炎动物模型的建立[J].胃肠病学,2001,6(1):7-10. 被引量:177
  • 6Sands BE, Kaplan GG. The role of TNFalpha in ulcerative colitis. J Clin Pharmacol, 2007, 47 (8): 930- 941.
  • 7Schindler JF, Monahan JB, Smith WG. p38 pathway kinases as anti-inflammatory drug targets. J Dent Res, 2007, 86 (9): 800-811.
  • 8Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy - from molecular mechanisms to therapeutie benefits. Biochim Biophys Acta, 2005, 1754 (1-2): 253-262.
  • 9Waetzig GH, Seegert D, Rosenstiel P, et al. p38 mitogenactivated protein kinase is activated and linked to TNF- alpha signaling in inflammatory bowel disease. J Immunol, 2002, 168 (10): 5342-5351.

二级参考文献7

  • 1Butzner JD, Parmar R, Bell CJ, Dalai V. Butyrateenema therapy stimulates mucosal repair in experimental colitis in the rat. Gut, 1996, 38: 568~573.
  • 2Dieleman LA, Palmen MJ, Akol H, Bloemena E,Pena AS, Meuwissen SG, Van Rees EP. Chronicexperimental colitis induced by dextran sulphatesodium (DSS) is characterized by Th1 and Th2 cy-tokines. Clin Exp Immunol, 1998, 114: 385~391.
  • 3Beagley KW, Black CA, Elson CO. Strain differences in susceptibility to TNBS-induced colitis(abstract). Gastroenterology, 1991, 100: A560.
  • 4Ward M. The pathogenesis of Crohn's disease.Lancet, 1977, 2: 903-905.
  • 5Shorter RG, Huizenga KA, Spencer RJ. A working hypothesis for the etiology and pathogenesisof nonspecific inflammatory bowel disease. Am JDig Dis, 1972, 17: 1024~ 1032.
  • 6Kunin S, Gallily R. Recognition and lysis of altered-self cells by macrophages. I. Modification oftarget cells by 2, 4, 6-trinitrobenzene sulphonicacid. Immunology, 1983, 48: 265~272.
  • 7Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism of trinitrobenzene sulfonic acid by the ratcolon produces reactive oxygen species. Gastroenterology, 1991, 101: 540~547.

共引文献188

同被引文献242

引证文献18

二级引证文献256

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部